Aurobindo Pharma Limited has announced a transition in its secretarial audit leadership. Following the resignation of M/s. MRR & Associates due to the health concerns of its proprietor, the company has appointed M/s. RPR & Associates as the new Secretarial Auditor. This appointment, approved by the Board on May 21, 2026, spans a five-year term beginning in the 2026-27 financial year.
Leadership Transition in Secretarial Audit
The company board met on May 21, 2026, to finalize changes regarding its secretarial audit functions. The outgoing firm, M/s. MRR & Associates, will step down effective May 22, 2026. The board acknowledged the firm’s departure, which was necessitated by the personal health circumstances of the sole proprietor.
Appointment of RPR & Associates
To ensure continuity and robust corporate governance, the company has appointed M/s. RPR & Associates, a Peer Reviewed Firm of Company Secretaries, as the successor. The appointment is for a term of five consecutive financial years, covering FY 2026-27 to FY 2030-31. This decision remains subject to formal approval by the shareholders during the company’s upcoming Annual General Meeting.
Firm Credentials
The new auditors, led by Mr. Y. Ravi Prasada Reddy, bring over 23 years of professional experience in corporate law and compliance. The firm is recognized for its specialized expertise in conducting secretarial audits, due diligence, and navigating complex regulatory frameworks, ensuring that Aurobindo Pharma maintains high standards of corporate oversight and operational transparency.
Source: BSE
